LONDON, May 7 /PRNewswire/ -- Senior executives in internationally dynamic software firms say that the current economic crisis will not significantly affect their European business models, according to The Software Report 2009. Dublin is the most positively perceived European location; the South East, London, Ile de France, West Nederland, Bavaria and Stockholm are considered to be the strongest cost/quality options for locating a European software facility. Northern Ireland has been the most successful regional location for software development centres between 2001 - 2008.

MACCLESFIELD, England, May 7 /PRNewswire/ -- Cyprotex today (7th May 2009) launches Cloe(R) Gateway, a new secure web portal for access to drug discovery services. The initial offering via Cloe(R) Gateway is a new enhanced version of our proprietary predictive software, Cloe(R) PK, which predicts whole body pharmacokinetics from simple in vitro ADME and physicochemical properties.

Commenting on the launch, Dr Anthony D. Baxter, Cyprotex's Chief Executive Officer, said:

LONDON, May 7 /PRNewswire/ --

The Frost Sullivan 2009 European Molecular Diagnostics for Infectious Diseases Product Line Strategy of the Year Award, is presented to SIRS-Lab GmbH. The company's exceptional product line for sepsis diagnosis and monitoring make it a worthy recipient of this award.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

Sepsis is the second commonest cause of death in industrialised countries. The major challenge for intensive care physicians is to be able to identify sepsis as early as possible to facilitate appropriate and effective treatment.

HAMBURG, May 7 /PRNewswire/ --

- Brightcove customers gain access to one of the leading global social media networks for videos and Web TV content

Brightcove Inc., the leading online video platform, today announced a partnership with sevenload, one of Europe's leading social media networks for videos, photos and Web TV content, to enable Brightcove customers to distribute online video content to sevenload's social media platform. This partnership will also introduce new monetization opportunities for Brightcove customers that are expanding their advertising inventory through distribution into the sevenload network. Brightcove customers already taking advantage of this new distribution opportunity include SPOX.com, a popular sports Web portal in Germany.

An international team of geologists may have uncovered the answer to an age-old question - an ice-age-old question, that is. It appears that Earth's earliest ice age may have been due to the rise of oxygen in Earth's atmosphere, which consumed atmospheric greenhouse gases and chilled the earth.

Scientists from the University of Maryland, including post-doctoral fellows Boswell Wing and Sang-Tae Kim, graduate student Margaret Baker, and professors Alan J. Kaufman and James Farquhar, along with colleagues in Germany, South Africa, Canada and the United States, uncovered evidence that the oxygenation of Earth's atmosphere - generally known as the Great Oxygenation Event - coincided with the first widespread ice age on the planet. 

VANCOUVER, May 7 /PRNewswire/ -- Sirius Genomics, a developer of pharmacogenomic diagnostics, announced today that it has signed a collaborative agreement with Vanderbilt University to study patients enrolled in Vanderbilt's Validating Acute Lung Injury biomarkers for Diagnosis (VALID) study. The agreement focuses on the continued development of Sirius' pharmacogenomic diagnostic. The diagnostic is intended to assess responsiveness to recombinant human activated Protein C (sold by Eli Lilly and Company under the trademark Xigris (R)) in patients with severe sepsis at high risk of death.

GENEVA, Switzerland, May 7 /PRNewswire/ --

- Additional Important Effects of Safinamide Noted in Ongoing Analyses of First Phase III Clinical Trial Done in Similar Patient Population (study 016)

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, and its partner Newron Pharmaceuticals SpA (SWX: NWRN) announced today the initiation of the SETTLE(1) study. This study will evaluate the efficacy and safety of a dose range of safinamide (50-100 mg once daily) as add-on therapy to a stable dose of levodopa, in mid- to late-stage Parkinson's disease patients with motor fluctuations compared to placebo.

LONDON, May 7 /PRNewswire/ -- A British computer software research company may have solved the growing problem of the Internet slowing down.

The software, called C-THRU is in the final stages of production, at Bubblephone Ltd, based at the University of Sussex Innovation Centre, near Brighton.

Experts predict that demand for Internet bandwidth, already growing at 60% a year, will start to exceed supply from as early as next year because of more people working online and the soaring popularity of bandwidth-hungry websites such as YouTube and services such as the BBC's iPlayer. The volume of traffic generated each month by YouTube is now equivalent to the amount of traffic generated across the entire Internet in all of 2000.

AMSTERDAM, May 7 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today the treatment of the first patient in a preregistration clinical trial with Glybera(TM). This gene therapy product targets lipoprotein lipase deficiency (LPLD), a seriously debilitating and potentially lethal disease.

The randomized controlled trial has been designed to gather additional data on the effects of Glybera on lipid metabolism and the mechanisms underlying the prevention of pancreatitis attacks. The trial is being performed under a Clinical Trial Application approved by Health Canada.

With obesity reaching epidemic numbers, cultural marketing  has long been attempting to tell women that they're beautiful no matter what size they are.   Perception is about to run up against medical health, according to a new study out of Temple University.

In the American Journal of Obstetrics and Gynecology research, Temple researchers studied the body image perceptions of 81 underweight, normal weight, overweight or obese women in the North Philadelphia area and found that as their body mass index (BMI) increased, two-thirds of the women still felt they were at an ideal body size.